Stem cell injunction: a lawyer’s eye view

Posted on by Nancy Fliesler
Posted in Ethics and policy
More On: ,

Judge Lamberth’s court injunction on federal funding of embryonic stem cell research was temporarily lifted September 9, but much remains in question. In today’s edition of Nature (September 23rd), a legal panel examines the case. Panelist Patrick Taylor, former Chief Counsel for Research Affairs at Children’s, weighs in on the ambiguities of the Dickey-Wicker amendment, what kind of legislative action is needed, and the prospects for NIH funding of research on the embryonic stem cell lines created under Obama, the so-called Bush Lines, and new lines waiting to be created.

Related Posts :

  • David

    I am a bioethicist based in San Diego. This afternoon I gave a presentation on stem cell research and related current events (including a discussion of Judge Lamberth’s ruling) to the National University Journal Club. Very well received with many questions from the audience.

    The talk was Part 2 of my ongoing talks on ESC research and human cloning.

    David Lemberg, M.S., D.C.
    http://davidlemberg.com

  • David

    I am a bioethicist based in San Diego. This afternoon I gave a presentation on stem cell research and related current events (including a discussion of Judge Lamberth's ruling) to the National University Journal Club. Very well received with many questions from the audience.

    The talk was Part 2 of my ongoing talks on ESC research and human cloning.

    David Lemberg, M.S., D.C.
    http://davidlemberg.com

  • an administration official says government lawyers will also argue that the injunction imposed by the judge will seriously jeopardize ongoing stem-cell research. Justice Department lawyers are now gathering

  • an administration official says government lawyers will also argue that the injunction imposed by the judge will seriously jeopardize ongoing stem-cell research. Justice Department lawyers are now gathering